COL·LABORA El Meu Clínic . Aquest enllaç s'obre en una nova pestanya.
Cerca
COL·LABORA El Meu Clínic . Aquest enllaç s'obre en una nova pestanya.
Fil de navegació

Gemma Fuster

Publicacions destacades

  • Understanding the microenvironment contribution to ductal carcinoma in situ transition to invasiveness in breast cancer

    Autors:
    Moragas, Nuria; Recalde-Percaz, Leire; Noguera-Castells, Aleix; Fernandez-Nogueira, Patricia; Mancino, Mario;
    Gascon, Pedro; Fuster, Gemma.
    Referència: CANCER RESEARCH.

  • Glucocorticoids mediate DCIS transition to IDC through myoepithelial cell apoptosis

    Autors:
    Zubeldia-Plazaola, Arantzazu; Recalde-Percaz, Leire; Moragas, Nuria; Mancino, Mario; Noguera, Aleix;
    Prats de Puig, Miquel; Guzman, Flavia; Gascon, Pedro; Bragado, Paloma; Fuster, Gemma.
    Referència: CANCER RESEARCH.

  • HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer

    Autors:
    Fernandez-Nogueira, Patricia; Noguera-Castells, Aleix; Fuster, Gemma; Recalde, Leire; Moragas, Nuria;
    (...)
    Jauregui, Patricia; Gascon, Pere; Carbo, Neus; Bragado, Paloma; Mancino, Mario;.
    Referència: CLINICAL AND EXPERIMENTAL METASTASIS.

  • STX1A signaling pathway characterization in different breast cancer subtypes

    Autors:
    Noguera-Castells, Aleix; Recalde-Percaz, Leire; Moragas, Nuria; Fernandez-Nogueira, Patricia; Fuster, Gemma;
    Bragado, Paloma; Gascon, Pere; Mancino, Mario;.
    Referència: CLINICAL AND EXPERIMENTAL METASTASIS.

  • NRP2-SEMA3s-PLXNs axis regulates the dormancy state of disseminated tumour cells and metastasis progression

    Autors:
    Recalde-Percaz, Leire; Noguera-Castells, Aleix; Moragas, Nuria; Mancino, Mario; Fernandez-Nogueira, Patricia;
    Fuster, Gemma; Gascon, Pere; Bragado, Paloma;.
    Referència: CLINICAL AND EXPERIMENTAL METASTASIS.

  • Substance P and its receptor NK1 regulates disseminated tumour cells biology and dormancy

    Autors:
    Recalde-Percaz, Leire; Jauregui, Patricia; Fernandez-Nogueira, Patricia; Alonso, Raul; Fuster, Gemma;
    Noguera-Castells, Aleix; Moragas, Nuria; Mancino, Mario; Gascon, Pere; Bragado, Paloma;.
    Referència: CLINICAL AND EXPERIMENTAL METASTASIS.

  • The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

    Autors:
    Erazo, Tatiana; Lorente, Mar; Lopez-Plana, Anna; Munoz-Guardiola, Pau; Fernandez-Nogueira, Patricia;
    (...)
    Gomez-Ferreria, Mariana; Alfon, Jose; Velasco, Guillermo; Domenech, Carles; Lizcano, Jose M.;.
    Referència: CLINICAL CANCER RESEARCH.

  • Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

    Autors:
    Fernández-Nogueira P.; Noguera-Castells A.; Fuster G.; Recalde-Percaz L.; Moragas N.;
    (...)
    Carbó N.; Almendro V.; Gascón P.; Bragado P.; Mancino M..
    Referència: CANCER LETTERS.

  • Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.

    Autors:
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F;
    (...)
    Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J .
    Referència: ONCOTARGET 2016.

Projectes destacats

  • Red temática de Investigaciones cooperativa del cáncer

    Investigador/a principal: Pere Gascón Vilaplana
    Finançador: INSTITUTO DE SALUD CARLOS III
    Durada: 01/01/2013

  • Plasticidad epigenética durante la adquisición de quimioresistencia en cáncer de colon

    Investigador/a principal: Cristina Nadal
    Finançador: INSTITUTO DE SALUD CARLOS III
    Durada: 01/01/2012